Suppr超能文献

挪威流感嗜血杆菌中产青霉素结合蛋白介导的β-内酰胺耐药性出现的突变 ftsI 基因。

Mutant ftsI genes in the emergence of penicillin-binding protein-mediated beta-lactam resistance in Haemophilus influenzae in Norway.

机构信息

Department of Microbiology, Vestfold Hospital, Tønsberg, Norway.

出版信息

Clin Microbiol Infect. 2010 Aug;16(8):1117-24. doi: 10.1111/j.1469-0691.2009.03052.x. Epub 2009 Sep 8.

Abstract

The most important mechanism for beta-lactam resistance in beta-lactamase-negative ampicillin-resistant (BLNAR) isolates of Haemophilus influenzae is the alteration of penicillin-binding protein 3 (PBP3) as a result of ftsI gene mutations. The present study aimed to map PBP3 alterations and to determine the correlation to beta-lactam resistance in respiratory tract isolates of H. influenzae in Norway, as well as assess the contribution of clonal spread to the emergence of PBP3-mediated resistance. Twenty-three beta-lactamase negative respiratory tract isolates with resistance to penicillins and 23 susceptible control isolates were examined by determination of beta-lactam MICs, ftsI sequencing and molecular typing by pulsed-field gel electrophoresis (PFGE). Ampicillin MIC ranges in the resistant group and the control group were 1-2 mg/L and 0.125-0.5 mg/L, respectively. All isolates in the resistant group had the PBP3 substitution Asn526-->Lys and were thus categorized as group II low-BLNAR. No control isolate met the genetic BLNAR (gBLNAR) criteria. The PBP3 substitution patterns corresponded well to those observed in previous European studies. Eighty-three percent (19/23) of the resistant isolates belonged to two clones, demonstrating the capability of low-BLNAR strains of clonal dissemination. Combined analysis of ftsI DNA sequences and PFGE patterns revealed distinctly different ftsI alleles in genetically indistinguishable isolates and identical copies of the same ftsI allele in unrelated isolates. A possible explanation of this observation is the recombinational exchange of ftsI alleles. This phenomenon, as well as the possibility of endemic European gBLNAR strains, should be further investigated.

摘要

β-内酰胺酶阴性、氨苄西林耐药(BLNAR)流感嗜血杆菌分离株中β-内酰胺耐药的最重要机制是青霉素结合蛋白 3(PBP3)的改变,这是由于 ftsI 基因突变所致。本研究旨在定位 PBP3 改变,并确定其与挪威呼吸道分离株中流感嗜血杆菌β-内酰胺耐药的相关性,以及评估克隆传播对 PBP3 介导的耐药性出现的贡献。对 23 株耐青霉素和 23 株敏感的β-内酰胺酶阴性呼吸道分离株进行了研究,方法是测定β-内酰胺 MIC、ftsI 测序和脉冲场凝胶电泳(PFGE)分子分型。耐药组和对照组的氨苄西林 MIC 范围分别为 1-2mg/L 和 0.125-0.5mg/L。耐药组的所有分离株均具有 PBP3 取代 Asn526-->Lys,因此归类为 II 组低 BLNAR。无对照分离株符合遗传 BLNAR(gBLNAR)标准。PBP3 取代模式与以前欧洲的研究结果一致。83%(19/23)的耐药分离株属于两个克隆,表明低 BLNAR 株具有克隆传播的能力。ftsI DNA 序列和 PFGE 图谱的综合分析显示,在遗传上无法区分的分离株中存在明显不同的 ftsI 等位基因,而在不相关的分离株中存在相同的 ftsI 等位基因的相同副本。这种观察结果的一个可能解释是 ftsI 等位基因的重组交换。这种现象以及流行的欧洲 gBLNAR 菌株的可能性应进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验